Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy

Introduction. Complete suppression of viral replication is crucial in chronic HCV treatment in order to prevent relapse and resistance development. We wanted to find out which factors influence the period from being already HCV RNA negative by bDNA assay (< 615 lU/mL) to become undetectable by th...

Descripció completa

Dades bibliogràfiques
Autors principals: Viola Knop, Gerlinde Teuber, Hartwig Klinker, Bernd Möller, Jens Rasenack, Holger Hinrichsen, Tilman Gerlach, Ulrich Spengler, Peter Buggisch, Konrad Neumann, Christoph Sarrazin, Stefan Zeuzem, Thomas Berg
Format: Article
Idioma:English
Publicat: Elsevier 2013-03-01
Col·lecció:Annals of Hepatology
Matèries:
Chronic hepatitis C
Early virologic kinetics
Minimal residual viremia
Treatment strategy
Accés en línia:http://www.sciencedirect.com/science/article/pii/S1665268119313560

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119313560

Ítems similars